STAT Media Bias

#JPM23 in review, the year ahead, & the merits of Miami

tech

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. With the 2023 J.P. Morgan Healthcare Conference drawing to a close, we look back on the biggest news of the meeting, what it means for the year in biotech ahead, and whether the industry’s biggest annual gathering might finally have outgrown its host city.
STAT Jan 13, 2023

Routine vaccinations drop among U.S. kindergartners for the third year in a row

health

The percentage of U.S. kindergartners who’ve received standard childhood vaccines took a small but notable dip into the 2021-2022 school year, health officials said Thursday, amid disruptions related to Covid-19 and fears that anti-vaccine sentiment stirred up by the pandemic could be spreading to other shots.
STAT Jan 13, 2023

Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug

health

For the third time in less than a year, a group of lawmakers is urging the Biden administration to use a controversial provision of federal law to widen access to a pricey cancer medicine, an issue that has festered ever since cancer patients petitioned the federal government.
STAT Jan 13, 2023

STAT+: Pharmalittle: Pfizer will not license generic Covid-19 pill in China; BioMarin signs outcomes-based deal in Germany for gene therapy

health

Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far and remember there are only a few more days until the weekend arrives. So keep plugging away. After all, what are the alternatives? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Remember that no prescription is required. Our choice today is peppermint mocha. Meanwhile, here is the latest menu of tidbits to help you on your way. Have a wonderful day, and please do stay in touch. …
STAT Jan 13, 2023

STAT+: HHS will seek more input on its new Medicare drug price negotiations

health

WASHINGTON — The Department of Health and Human Services is gearing up to start releasing details about its new Medicare drug price negotiation process this year, and the public will have more of a chance to weigh in along the way than initially expected, officials said Wednesday.
STAT Jan 13, 2023

STAT+: Top Verily executives depart amid leadership shakeup and layoffs

health

According to a memo exclusively obtained by STAT, Amy Abernethy, the former Food and Drug Administration official that Verily brought on to advance the use of technology in speeding up clinical trials, will be elevated to president of product development and chief medical officer.
STAT Jan 13, 2023

For most mild infections, long Covid symptoms clear after a year, large study finds

health

Since long Covid emerged, how best to define it, predict it, and treat it has been up for debate, but perhaps the most urgent question for patients and providers alike has been how long it lasts. A new study analyzing nearly 2 million patient records in Israel concludes that for most people, the troubling symptoms that persist after a mild Covid infection fade away after about a year.
STAT Jan 13, 2023

STAT+: Drastic changes should bring profitability, startup health insurers say

health

Startup insurers Oscar Health, Bright Health, and Clover Health have hemorrhaged money since going public within the past two years. All three used their stage time at the J.P. Morgan Healthcare Conference to make the case that their drastic decisions — like fully exiting some insurance markets — will deliver the profitability investors are demanding.
STAT Jan 13, 2023

STAT+: Medicare paves the way for CAR-T in doctors offices

health

CAR-T is a relatively new medical procedure that uses a person’s own cells to fight their cancer, and it offers hope of a cure for those who have run out of options. It’s a complex procedure with a lot of serious side effects that must be closely monitored, so it’s typically provided at hospitals in the inpatient setting, sometimes outpatient, and almost never in doctor offices.
STAT Jan 13, 2023

STAT+: BioNTech CEO lays out vision for how mRNA and AI can power personalized medicine

tech

SAN FRANCISCO — When BioNTech was founded in 2008, messenger RNA therapies and vaccines were still an unproven idea. The German company has now shipped out billions of doses of its mRNA Covid-19 vaccine worldwide — and BioNTech’s leaders say that’s just the beginning of a larger revolution in medicine.
STAT Jan 13, 2023

How medical schools are missing the mark on artificial intelligence

health

Ready or not, health care is undergoing a massive transformation driven by artificial intelligence. But medical schools have barely started to teach about AI and machine learning — creating knowledge gaps that could compound the damage caused by flawed algorithms and biased decision-support systems.
STAT Jan 13, 2023

Upstart Element ratchets up race for cheaper DNA sequencing with a $200 genome - STAT

health

SAN FRANCISCO — Decoding the billions of chemical letters that help shape who we are once cost a fortune. But genomics startup Element Biosciences on Wednesday announced it can now read a whole human genome for as little as $200 — the cost of a couple trips to the grocery store.
STAT Jan 12, 2023

Uncover sensationalism, opinion, and topical biases from STAT. Updated weekly.

STAT Social Media Impact (?): 33

STAT Publishes More About

STAT Most Similar Sources (?)

STAT Recent Articles

#JPM23 in review, the year ahead, & the merits of Miami

Routine vaccinations drop among U.S. kindergartners for the third year in a row

Lawmakers again urge the Biden administration to use federal law to widen access to a cancer drug

STAT+: Pharmalittle: Pfizer will not license generic Covid-19 pill in China; BioMarin signs outcomes-based deal in Germany for gene therapy

STAT+: HHS will seek more input on its new Medicare drug price negotiations

STAT+: Top Verily executives depart amid leadership shakeup and layoffs

For most mild infections, long Covid symptoms clear after a year, large study finds

STAT+: Drastic changes should bring profitability, startup health insurers say

STAT+: Medicare paves the way for CAR-T in doctors offices

STAT+: BioNTech CEO lays out vision for how mRNA and AI can power personalized medicine

How medical schools are missing the mark on artificial intelligence

Upstart Element ratchets up race for cheaper DNA sequencing with a $200 genome - STAT

Market Forecasts

Balanced News

Volatility Forecasts

Getting Started

Deepen your understanding & become a more profitable investor with Helium.